FDA approves Madrigal Pharmaceuticals’ Rezdiffra for NASH, a breakthrough in fatty liver treatment, opening new possibilities for patients
US FDA Approves First Drug For Fatty Liver Disease NASH
- Post author:
- Post published:March 15, 2024
- Post category:Blog
- Post comments:0 Comments